Annual Cost Of Goods Sold
$1.82 B
+$255.40 M+16.37%
31 December 2023
Summary:
Regeneron Pharmaceuticals annual cost of goods sold is currently $1.82 billion, with the most recent change of +$255.40 million (+16.37%) on 31 December 2023. During the last 3 years, it has risen by +$695.90 million (+62.14%). REGN annual cost of goods sold is now -25.51% below its all-time high of $2.44 billion, reached on 31 December 2021.REGN Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cost Of Goods Sold
$491.10 M
+$10.90 M+2.27%
30 September 2024
Summary:
Regeneron Pharmaceuticals quarterly cost of goods sold is currently $491.10 million, with the most recent change of +$10.90 million (+2.27%) on 30 September 2024. Over the past year, it has increased by +$54.70 million (+12.53%). REGN quarterly cost of goods sold is now -50.02% below its all-time high of $982.60 million, reached on 31 December 2021.REGN Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Cost Of Goods Sold
$1.92 B
+$54.70 M+2.93%
30 September 2024
Summary:
Regeneron Pharmaceuticals TTM cost of goods sold is currently $1.92 billion, with the most recent change of +$54.70 million (+2.93%) on 30 September 2024. Over the past year, it has increased by +$82.70 million (+4.50%). REGN TTM cost of goods sold is now -24.16% below its all-time high of $2.53 billion, reached on 31 March 2022.REGN TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REGN Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.4% | +12.5% | +4.5% |
| 3 y3 years | +62.1% | +8.4% | +6.3% |
| 5 y5 years | +334.9% | +117.8% | +198.5% |
REGN Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -25.5% | +62.1% | -50.0% | +65.3% | -24.2% | +23.2% |
| 5 y | 5 years | -25.5% | +334.9% | -50.0% | +126.0% | -24.2% | +198.5% |
| alltime | all time | -25.5% | >+9999.0% | -50.0% | >+9999.0% | -24.2% | >+9999.0% |
Regeneron Pharmaceuticals Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $491.10 M(+2.3%) | $1.92 B(+2.9%) |
| June 2024 | - | $480.20 M(+10.7%) | $1.87 B(+4.2%) |
| Mar 2024 | - | $433.80 M(-16.1%) | $1.79 B(-1.3%) |
| Dec 2023 | $1.82 B(+16.4%) | $517.00 M(+18.5%) | $1.82 B(-1.3%) |
| Sept 2023 | - | $436.40 M(+7.8%) | $1.84 B(+6.9%) |
| June 2023 | - | $404.90 M(-11.5%) | $1.72 B(+6.7%) |
| Mar 2023 | - | $457.50 M(-15.4%) | $1.61 B(+3.4%) |
| Dec 2022 | $1.56 B(-36.0%) | $540.60 M(+70.1%) | $1.56 B(-22.1%) |
| Sept 2022 | - | $317.80 M(+7.0%) | $2.00 B(-6.3%) |
| June 2022 | - | $297.10 M(-26.6%) | $2.14 B(-15.6%) |
| Mar 2022 | - | $404.90 M(-58.8%) | $2.53 B(+4.0%) |
| Dec 2021 | $2.44 B(+117.7%) | $982.60 M(+116.8%) | $2.44 B(+34.8%) |
| Sept 2021 | - | $453.20 M(-34.7%) | $1.81 B(+11.0%) |
| June 2021 | - | $693.70 M(+125.2%) | $1.63 B(+34.5%) |
| Mar 2021 | - | $308.00 M(-12.8%) | $1.21 B(+8.1%) |
| Dec 2020 | $1.12 B(+46.4%) | $353.10 M(+28.9%) | $1.12 B(+13.3%) |
| Sept 2020 | - | $274.00 M(-0.5%) | $988.50 M(+5.2%) |
| June 2020 | - | $275.50 M(+26.8%) | $940.00 M(+16.0%) |
| Mar 2020 | - | $217.30 M(-2.0%) | $810.30 M(+5.9%) |
| Dec 2019 | $765.10 M(+83.3%) | $221.70 M(-1.7%) | $765.10 M(+18.8%) |
| Sept 2019 | - | $225.50 M(+54.7%) | $643.90 M(+21.8%) |
| June 2019 | - | $145.80 M(-15.3%) | $528.80 M(+11.4%) |
| Mar 2019 | - | $172.10 M(+71.2%) | $474.70 M(+13.7%) |
| Dec 2018 | $417.50 M(+5.1%) | $100.50 M(-9.0%) | $417.50 M(-1.2%) |
| Sept 2018 | - | $110.40 M(+20.4%) | $422.78 M(+1.5%) |
| June 2018 | - | $91.70 M(-20.2%) | $416.61 M(-2.6%) |
| Mar 2018 | - | $114.90 M(+8.6%) | $427.83 M(+7.7%) |
| Dec 2017 | $397.10 M(+32.5%) | $105.78 M(+1.5%) | $397.10 M(+8.5%) |
| Sept 2017 | - | $104.23 M(+1.3%) | $366.01 M(+19.6%) |
| June 2017 | - | $102.92 M(+22.3%) | $306.00 M(+12.5%) |
| Mar 2017 | - | $84.17 M(+12.7%) | $272.12 M(-9.2%) |
| Dec 2016 | $299.70 M(-23.7%) | $74.69 M(+68.9%) | $299.70 M(-10.8%) |
| Sept 2016 | - | $44.23 M(-35.9%) | $335.84 M(-16.2%) |
| June 2016 | - | $69.03 M(-38.2%) | $400.70 M(-4.7%) |
| Mar 2016 | - | $111.75 M(+0.8%) | $420.51 M(+7.1%) |
| Dec 2015 | $392.71 M(+91.5%) | $110.83 M(+1.6%) | $392.71 M(+15.0%) |
| Sept 2015 | - | $109.08 M(+22.8%) | $341.35 M(+18.6%) |
| June 2015 | - | $88.84 M(+5.8%) | $287.86 M(+17.3%) |
| Mar 2015 | - | $83.95 M(+41.2%) | $245.40 M(+19.7%) |
| Dec 2014 | $205.02 M(+32.0%) | $59.47 M(+7.0%) | $205.02 M(+5.9%) |
| Sept 2014 | - | $55.59 M(+19.9%) | $193.66 M(+9.6%) |
| June 2014 | - | $46.38 M(+6.4%) | $176.64 M(+4.0%) |
| Mar 2014 | - | $43.57 M(-9.4%) | $169.87 M(+9.3%) |
| Dec 2013 | $155.35 M(+84.0%) | $48.11 M(+24.7%) | $155.35 M(+13.1%) |
| Sept 2013 | - | $38.57 M(-2.6%) | $137.41 M(+15.5%) |
| June 2013 | - | $39.61 M(+36.3%) | $118.98 M(+17.6%) |
| Mar 2013 | - | $29.05 M(-3.7%) | $101.21 M(+19.8%) |
| Dec 2012 | $84.45 M(+1903.2%) | $30.17 M(+49.8%) | $84.45 M(+47.5%) |
| Sept 2012 | - | $20.14 M(-7.8%) | $57.27 M(+52.4%) |
| June 2012 | - | $21.84 M(+77.6%) | $37.58 M(+133.0%) |
| Mar 2012 | - | $12.30 M(+311.4%) | $16.13 M(+282.6%) |
| Dec 2011 | $4.22 M(+101.4%) | $2.99 M(+564.2%) | $4.22 M(+130.9%) |
| Sept 2011 | - | $450.00 K(+13.9%) | $1.83 M(+4.5%) |
| June 2011 | - | $395.00 K(+3.4%) | $1.75 M(-0.6%) |
| Mar 2011 | - | $382.00 K(-36.2%) | $1.76 M(-16.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | $2.09 M(+24.1%) | $599.00 K(+61.0%) | $2.09 M(+11.3%) |
| Sept 2010 | - | $372.00 K(-8.1%) | $1.88 M(-5.0%) |
| June 2010 | - | $405.00 K(-43.5%) | $1.98 M(-1.5%) |
| Mar 2010 | - | $717.00 K(+85.3%) | $2.01 M(+19.3%) |
| Dec 2009 | $1.69 M(+82.7%) | $387.00 K(-18.0%) | $1.69 M(-12.6%) |
| Sept 2009 | - | $472.00 K(+8.5%) | $1.93 M(+10.3%) |
| June 2009 | - | $435.00 K(+11.0%) | $1.75 M(+33.1%) |
| Mar 2009 | - | $392.00 K(-37.9%) | $1.31 M(+42.5%) |
| Dec 2008 | $923.00 K(-88.7%) | $631.00 K(+116.1%) | $923.00 K(+216.1%) |
| Sept 2008 | - | $292.00 K(-32.1%) | $292.00 K(-96.4%) |
| Dec 2006 | $8.15 M(-14.8%) | $430.00 K(-85.9%) | $8.15 M(-17.4%) |
| Sept 2006 | - | $3.05 M(+8.7%) | $9.86 M(-1.9%) |
| June 2006 | - | $2.81 M(+51.7%) | $10.05 M(+12.7%) |
| Mar 2006 | - | $1.85 M(-13.7%) | $8.92 M(-6.7%) |
| Dec 2005 | $9.56 M(-37.2%) | $2.15 M(-33.9%) | $9.56 M(-12.2%) |
| Sept 2005 | - | $3.25 M(+93.8%) | $10.89 M(-34.5%) |
| June 2005 | - | $1.68 M(-32.8%) | $16.63 M(+7.4%) |
| Mar 2005 | - | $2.49 M(-28.3%) | $15.48 M(+1.7%) |
| Dec 2004 | $15.21 M(+127.9%) | $3.47 M(-61.3%) | $15.21 M(+20.3%) |
| Sept 2004 | - | $8.99 M(+1598.7%) | $12.65 M(+48.7%) |
| June 2004 | - | $529.00 K(-76.2%) | $8.51 M(+3.3%) |
| Mar 2004 | - | $2.23 M(+145.3%) | $8.23 M(+23.4%) |
| Dec 2003 | $6.68 M(+3.0%) | $907.00 K(-81.3%) | $6.68 M(-10.9%) |
| Sept 2003 | - | $4.84 M(+1770.3%) | $7.50 M(+74.8%) |
| June 2003 | - | $259.00 K(-61.1%) | $4.29 M(-27.2%) |
| Mar 2003 | - | $666.00 K(-61.4%) | $5.89 M(-9.1%) |
| Dec 2002 | $6.48 M(-0.4%) | $1.73 M(+5.4%) | $6.48 M(+9.5%) |
| Sept 2002 | - | $1.64 M(-12.0%) | $5.92 M(+6.5%) |
| June 2002 | - | $1.86 M(+47.8%) | $5.56 M(-0.4%) |
| Mar 2002 | - | $1.26 M(+8.3%) | $5.58 M(-14.3%) |
| Dec 2001 | $6.51 M(-58.2%) | $1.16 M(-8.8%) | $6.51 M(-53.8%) |
| Sept 2001 | - | $1.27 M(-32.4%) | $14.09 M(-8.1%) |
| June 2001 | - | $1.89 M(-13.8%) | $15.32 M(+4.2%) |
| Mar 2001 | - | $2.19 M(-75.0%) | $14.70 M(-5.5%) |
| Dec 2000 | $15.57 M(+332.4%) | $8.74 M(+247.9%) | $15.57 M(+124.7%) |
| Sept 2000 | - | $2.51 M(+98.6%) | $6.93 M(+27.9%) |
| June 2000 | - | $1.26 M(-58.5%) | $5.42 M(+1.2%) |
| Mar 2000 | - | $3.05 M(+2951.0%) | $5.35 M(+48.6%) |
| Dec 1999 | $3.60 M(-28.0%) | $100.00 K(-90.0%) | $3.60 M(-29.4%) |
| Sept 1999 | - | $1.00 M(-16.7%) | $5.10 M(-5.6%) |
| June 1999 | - | $1.20 M(-7.7%) | $5.40 M(0.0%) |
| Mar 1999 | - | $1.30 M(-18.8%) | $5.40 M(+8.0%) |
| Dec 1998 | $5.00 M(+92.3%) | $1.60 M(+23.1%) | $5.00 M(+16.3%) |
| Sept 1998 | - | $1.30 M(+8.3%) | $4.30 M(+13.2%) |
| June 1998 | - | $1.20 M(+33.3%) | $3.80 M(+22.6%) |
| Mar 1998 | - | $900.00 K(0.0%) | $3.10 M(+14.8%) |
| Dec 1997 | $2.60 M(+136.4%) | $900.00 K(+12.5%) | $2.70 M(+50.0%) |
| Sept 1997 | - | $800.00 K(+60.0%) | $1.80 M(+80.0%) |
| June 1997 | - | $500.00 K(0.0%) | $1.00 M(+100.0%) |
| Mar 1997 | - | $500.00 K(-95.3%) | $500.00 K(-95.3%) |
| Dec 1996 | $1.10 M(-91.4%) | - | - |
| Sept 1993 | - | $10.60 M(+112.0%) | $10.60 M(+2.9%) |
| Dec 1991 | $12.80 M(+103.2%) | $5.00 M(+108.3%) | $10.30 M(+94.3%) |
| Sept 1991 | - | $2.40 M(-17.2%) | $5.30 M(+82.8%) |
| June 1991 | - | $2.90 M | $2.90 M |
| Dec 1990 | $6.30 M | - | - |
FAQ
- What is Regeneron Pharmaceuticals annual cost of goods sold?
- What is the all time high annual cost of goods sold for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual cost of goods sold year-on-year change?
- What is Regeneron Pharmaceuticals quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly cost of goods sold year-on-year change?
- What is Regeneron Pharmaceuticals TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM cost of goods sold year-on-year change?
What is Regeneron Pharmaceuticals annual cost of goods sold?
The current annual cost of goods sold of REGN is $1.82 B
What is the all time high annual cost of goods sold for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual cost of goods sold is $2.44 B
What is Regeneron Pharmaceuticals annual cost of goods sold year-on-year change?
Over the past year, REGN annual cost of goods sold has changed by +$255.40 M (+16.37%)
What is Regeneron Pharmaceuticals quarterly cost of goods sold?
The current quarterly cost of goods sold of REGN is $491.10 M
What is the all time high quarterly cost of goods sold for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly cost of goods sold is $982.60 M
What is Regeneron Pharmaceuticals quarterly cost of goods sold year-on-year change?
Over the past year, REGN quarterly cost of goods sold has changed by +$54.70 M (+12.53%)
What is Regeneron Pharmaceuticals TTM cost of goods sold?
The current TTM cost of goods sold of REGN is $1.92 B
What is the all time high TTM cost of goods sold for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM cost of goods sold is $2.53 B
What is Regeneron Pharmaceuticals TTM cost of goods sold year-on-year change?
Over the past year, REGN TTM cost of goods sold has changed by +$82.70 M (+4.50%)